Skip to main content
Journal cover image

Beyond mere obesity: effect of increasing obesity classifications on hysterectomy outcomes for uterine cancer/hyperplasia.

Publication ,  Journal Article
Giugale, LE; Di Santo, N; Smolkin, ME; Havrilesky, LJ; Modesitt, SC
Published in: Gynecol Oncol
November 2012

OBJECTIVE: To assess the impact of obesity severity on hysterectomy outcomes for uterine hyperplasia/cancer. METHODS: The data from women undergoing hysterectomies for endometrial hyperplasia/uterine cancer with a BMI≥30 kg/m(2) were abstracted from records at the University of Virginia and Duke University following IRB approval. Univariate and multivariate statistical analyses were performed. RESULTS: Mean age of the 659 patients was 58.1 yrs; mean body mass index (BMI) was 43 kg/m(2). Women were grouped based on BMI: 39.6% (261) were obese (30-39 kg/m(2)), 41.7% (275) were morbidly obese (40-49 kg/m(2)) and 18.7% (123) were super obese (≥50 kg/m(2)). Minimally invasive surgical procedures (MIS) were attempted in 280 patients with a conversion rate of 16.1%; BMI was higher in the converted group (47.3 vs. 40.6 kg/m(2); p<0.001). As obesity group increased, there was a decreased frequency of lymphadenectomy (63.8% vs. 37.1% vs. 20.3%; p<0.001), increased blood loss (242 vs. 281 vs. 378 mL; p<0.001) and fewer nodes removed (p<0.001). On multivariate analysis, type of surgery (open vs. MIS) and obesity classification were independently and significantly associated with wound complications (p<0.001) and the presence of postoperative complications (p<0.001, p=0.003). Surgical staging with lymphadenectomy was significantly associated with obesity (p<0.001) but not procedure type (p=0.11). Blood transfusion (p<0.001), hospital readmission (p=0.025), and ileus (p<0.001) were significantly associated with open procedures but not obesity. There were no significant differences in progression-free or disease-specific survival based on obesity group. CONCLUSION: Women with BMI's exceeding 40 kg/m(2) have worse surgical outcomes than their less obese counterparts.

Duke Scholars

Published In

Gynecol Oncol

DOI

EISSN

1095-6859

Publication Date

November 2012

Volume

127

Issue

2

Start / End Page

326 / 331

Location

United States

Related Subject Headings

  • Uterine Neoplasms
  • Treatment Outcome
  • Severity of Illness Index
  • Retrospective Studies
  • Postoperative Complications
  • Oncology & Carcinogenesis
  • Obesity, Morbid
  • Obesity
  • Neoplasm Staging
  • Multivariate Analysis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Giugale, L. E., Di Santo, N., Smolkin, M. E., Havrilesky, L. J., & Modesitt, S. C. (2012). Beyond mere obesity: effect of increasing obesity classifications on hysterectomy outcomes for uterine cancer/hyperplasia. Gynecol Oncol, 127(2), 326–331. https://doi.org/10.1016/j.ygyno.2012.08.014
Giugale, Lauren E., Nicola Di Santo, Mark E. Smolkin, Laura J. Havrilesky, and Susan C. Modesitt. “Beyond mere obesity: effect of increasing obesity classifications on hysterectomy outcomes for uterine cancer/hyperplasia.Gynecol Oncol 127, no. 2 (November 2012): 326–31. https://doi.org/10.1016/j.ygyno.2012.08.014.
Giugale LE, Di Santo N, Smolkin ME, Havrilesky LJ, Modesitt SC. Beyond mere obesity: effect of increasing obesity classifications on hysterectomy outcomes for uterine cancer/hyperplasia. Gynecol Oncol. 2012 Nov;127(2):326–31.
Giugale, Lauren E., et al. “Beyond mere obesity: effect of increasing obesity classifications on hysterectomy outcomes for uterine cancer/hyperplasia.Gynecol Oncol, vol. 127, no. 2, Nov. 2012, pp. 326–31. Pubmed, doi:10.1016/j.ygyno.2012.08.014.
Giugale LE, Di Santo N, Smolkin ME, Havrilesky LJ, Modesitt SC. Beyond mere obesity: effect of increasing obesity classifications on hysterectomy outcomes for uterine cancer/hyperplasia. Gynecol Oncol. 2012 Nov;127(2):326–331.
Journal cover image

Published In

Gynecol Oncol

DOI

EISSN

1095-6859

Publication Date

November 2012

Volume

127

Issue

2

Start / End Page

326 / 331

Location

United States

Related Subject Headings

  • Uterine Neoplasms
  • Treatment Outcome
  • Severity of Illness Index
  • Retrospective Studies
  • Postoperative Complications
  • Oncology & Carcinogenesis
  • Obesity, Morbid
  • Obesity
  • Neoplasm Staging
  • Multivariate Analysis